Take Control
Manage CKD in stages 1-3b through a PCP-driven approach
Take Control
Through reliable & actionable risk stratification
Take Control
Make better decisions as to which patients can benefit most from therapeutics
Take Control
By deploying resources most efficiently: only the right patients referred to nephrology
Take Control
Drive improved quality of care and HEDIS metrics
Take Control
Better manage ACO, VBC and risk contracts by improving preemptive, upstream care.
KidneyIntelX is the
one test that helps PCPs make more informed decisions.
KidneyIntelX is the only bioprognostic methodology for demonstrated risk assessment of adult patients with type 2 diabetes and chronic kidney disease stages 1-3b.
- Low scoring patients have an approximate 90% chance of not experiencing DKD progression1,2
- High scoring patients have an approximate 70% chance of experiencing DKD progression1